Other inhibitors, like KU-59403, specifically enhance the effects of topoisomerase poisons in colon cancer, while AZ31 and AZD0156, dual ATM/ATR inhibitors, exhibit synergy with chemotherapy in colorectal and triple-negative breast cancer. Here, ATR is linked to malignant colon neoplasm.